Acrux Limited (ASX:ACR)
Australia · Delayed Price · Currency is AUD 0.0150
0.00 (0.00%)
Jun 19, 2026, 3:02 PM AEST
Acrux Market Cap
Acrux has a market cap or net worth of 7.7 million as of June 18, 2026. Its market cap has decreased by -17.82% in one year.
Market Cap
7.70M
Enterprise Value
8.95M
Revenue
2.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since September 29, 2004, Acrux's market cap has decreased from 90.77M to 7.70M, a decrease of -91.52%. That is a compound annual growth rate of -10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 7.70M | 25.00% |
| Dec 31, 2025 | 6.16M | -53.60% |
| Dec 31, 2024 | 13.27M | 4.16% |
| Dec 29, 2023 | 12.74M | -36.43% |
| Dec 30, 2022 | 20.05M | -29.33% |
| Dec 31, 2021 | 28.37M | -18.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Argenica Therapeutics | 14.13M |
| Cambium Bio | 12.98M |
| Immuron | 9.80M |
| Invex Therapeutics | 9.77M |
| Vectus Biosystems | 9.22M |
| AdAlta | 7.97M |
| Biotron | 6.75M |
| Bio-Gene Technology | 6.10M |